Skip to main content

Table 2 Imaging data among COVID-19 + soldiers (soldier cases) compared to soldier controls

From: Cardiovascular magnetic resonance evaluation of soldiers after recovery from symptomatic SARS-CoV-2 infection: a case–control study of cardiovascular post-acute sequelae of SARS-CoV-2 infection (CV PASC)

 

Soldier cases

(N = 50)

Soldier healthy controls

(N = 50)

P value

LVEF, median (IQR), %

59.5 (56.9, 63.0)

57.8 (55.7, 61.3)

0.24

LVEDV, mL

178.0 (162.2, 201.4)

188.5 (165.2, 211.6)

0.12

LVEDVI, mL/m2

84.9 (79.8, 94.5)

91.2 (82.6, 103.0)

0.059

LVESV, mL

70.6 (61.2, 85.6)

78.8 (61.9, 89.2)

0.17

LVESVI, mL/m2

34.6 (30.1, 39.4)

39.2 (31.8, 44.6)

0.025

LV mass, g

134.3 (116.1, 146.1)

122.9 (110.4, 139.5)

0.06

LV mass index, g/m2

64.6 (58.4, 69.1)

59.6 (55.6, 65.5)

0.023

RVEF, %

51.0 (48.5, 54.0)

53.2 (50.8, 58.7)

0.012

RVEDV, mL

200.8 (178.0, 224.8)

183.2 (168.9, 237.0)

0.33

RVEDVI, mL/m2

98.0 (86.9, 109.5)

93.8 (80.6, 109.5)

0.35

RVESV, mL

100.5 (85.7, 116.1)

85.3 (70.7, 110.6)

0.10

RVESVI, mL/m2

47.8 (42.6, 55.2)

43.1 (34.6, 51.1)

0.052

T1, median (IQR), ms

   

 Mid septum

982.2 (953.6, 991.7)

982.8 (966.0, 998.6)b

0.22

 Mid lateral

970.7 (952.9, 985.1)

964.5 (948.3, 987.0)b

0.42

 Mid global

971.5 (953.4, 985.8)

972.5 (961.7, 987.6)b

0.44

T2 median (IQR), ms

   

 Mid septum

45.3 (43.8, 46.7)c

44.8 (43.9, 46.3)d

0.71

 Mid lateral

45.1 (43.7, 45.9)c

45.4 (44.0, 46.7)d

0.72

 Mid global

45.3 (44.3, 46.3)c

45.4 (44.4, 46.3)d

0.69

ECV (global), %

   

 Mid septum

23.6 (22.1, 25.2)c

22.7 (21.9, 23.1)e

0.38

 Mid lateral

22.1 (20.5, 22.9)c

20.8 (20.7, 22.4)e

0.58

 Mid global

23.0 (21.3, 24.1)f

22.3 (22.0, 24.3)g

0.97

LGE

   

 Any, N (%)

11 (22.5%)h

8 (23.5%)i

0.56

 Inferior RV septal insertion

8 (16%)c

8 (23.5%)i

0.09

 Subepicardial inferolateral

4 (8%)c

0 (0%)i

0.03

Diagnosis

   

 Myocarditis

4 (8%)

0 (0%)

 

 Takotsubo cardiomyopathy

1 (2%)

0 (0%)

 
  1. ECV extracellular volume, LGE late gadolinium enhancement, LV left ventricle, LVEDV left ventricular end-diastolic volume, LVEDVI left ventricular end-diastolic volume index, LVEF left ventricular ejection fraction, LVESV left ventricular end-systolic volume, LVESVI left ventricular end-systolic volume index, RVEDV right ventricular end-diastolic volume, RVEDVI right ventricular end-diastolic volume index, RVEF right ventricular ejection fraction, RVESV right ventricular end-systolic volume, RVESVI right ventricular end-systolic volume index, n/a not applicable
  2. aN = 11
  3. bN = 48
  4. cN = 47
  5. dN = 13
  6. eN = 5
  7. fN = 46
  8. gN = 4
  9. hN = 49
  10. iN = 34